| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | 0.076 | 0.2 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.2 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | -0.26 | 0.2 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.088 | 0.2 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |